Purification and characterization of human platelet proteoglycan.
about
Characterization and N-terminal sequence of human platelet proteoglycanRegulation of expression of megakaryocyte and platelet proteoglycansComplement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis.Serglycin in human cancersContribution of chondroitin sulfate A to the binding of complement proteins to activated platelets.Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets.Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).Platelets and autoimmunity.Reincarnation of ancient links between coagulation and complement.Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammation.Small proteoglycans.Modifications in the synthesis of membrane-associated chondroitin sulfate proteoglycans in hemopoietic progenitor cells are accompanied by alterations in their adhesive properties.Proteoglycan synthesis in human erythroleukaemia (HEL) cellsMetabolic properties of a homogeneous proteoglycan of a haemopoietic stem cell line, FDCP-mix.Dose dependent effects of platelet derived chondroitinsulfate A on the binding of CCL5 to endothelial cells.
P2860
Q24528191-6D05D23E-C62A-43FD-B853-C963988978F8Q28139959-B7C20F83-FF12-4E28-B00F-D875BB7823F0Q33388175-BCDA5648-648E-4E9E-944E-2BBB94D97A32Q33418371-EACB4FA5-CA90-417E-B62E-B98EA07EC80DQ33579353-20404287-04AA-47FC-B22F-E74CD8ADAE06Q33707764-AB55A670-CCF5-4DBE-836A-B02774E59C6AQ37170034-E20E600B-1925-4790-B77E-7BC2BE2F17D3Q37200463-64E216D8-587E-4C3E-9302-F41FBB63DFC1Q38101678-01C17F6C-4EF9-463A-A517-6F5F3D4AC941Q38543278-E21387F5-E785-4309-9BEC-1B58912EF68AQ38991010-BA16BA5A-AF8F-4FEA-9B14-1B4578C9FA09Q40910732-A1F9FB90-C21F-4F31-BBAA-655DED946EC6Q41476512-76381113-9F12-4D7C-84E7-3C8C53BAA37AQ41887611-47C5620F-B018-4492-AD49-0DD8A4765E40Q42836323-2B3324EE-7A57-43E5-9E34-CB9282A8C0D5Q43211595-2C78614B-352B-41E8-BAA8-10DCD4E38361
P2860
Purification and characterization of human platelet proteoglycan.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Purification and characterization of human platelet proteoglycan.
@en
Purification and characterization of human platelet proteoglycan.
@nl
type
label
Purification and characterization of human platelet proteoglycan.
@en
Purification and characterization of human platelet proteoglycan.
@nl
prefLabel
Purification and characterization of human platelet proteoglycan.
@en
Purification and characterization of human platelet proteoglycan.
@nl
P2093
P2860
P356
P1433
P1476
Purification and characterization of human platelet proteoglycan.
@en
P2093
Fujiwara Y
Nakanishi H
Yonekura H
P2860
P356
10.1042/BJ2330073
P407
P577
1986-01-01T00:00:00Z